Our weight loss program helps you lose up to 15% of body weight by utilizing a GLP-1 class medication, together with sensible diet and exercise.
Glucagon-like peptide-1 (GLP-1) agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity.
PLEASE REVIEW THE MEDICATION OPTION BELOW. OUR PROVIDER WILL DISCUSS THESE OPTIONS FOR SAFETY, AFFICACY AND COST.
WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine that may help adults and children aged ≥12 years with obesity (BMI ≥30 for adults, BMI ≥ 95th percentile for age and sex for children), or some adults with excess weight (BMI ≥27) (overweight) who also have weight-related medical problems to help them lose weight and keep it off. Wegovy® should be used with a reduced calorie meal plan and increased physical activityWegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicinesIt is not known if Wegovy® is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss productsIt is not known if Wegovy® can be used safely in people with a history of pancreatitisIt is not known if Wegovy® is safe and effective for use in children under 12 years of age
Tirzepatide, sold under the brand name Mounjaro among others, is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered through subcutaneous injection.
The defining characteristic of compounded semaglutide lies in its fusion of traditional semaglutide with other body-safe vitamins, such as B12. Semaglutide, a GLP1 receptor agonist, was initially engineered to combat diabetes by regulating blood glucose levels through the stimulation of insulin release.
Compounded semaglutide is not currently offered in Alabama, Alaska, Arkansas, California, Hawaii, Louisiana, Mississippi, Virginia, and the District of Columbia.
